A detailed history of Northern Trust Corp transactions in Biogen Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,353,135 shares of BIIB stock, worth $214 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,353,135
Previous 1,425,921 5.1%
Holding current value
$214 Million
Previous $331 Million 20.65%
% of portfolio
0.04%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$189.07 - $236.8 $13.8 Million - $17.2 Million
-72,786 Reduced 5.1%
1,353,135 $262 Million
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $7.15 Million - $8.89 Million
37,535 Added 2.7%
1,425,921 $331 Million
Q1 2024

May 14, 2024

SELL
$212.02 - $267.71 $22.6 Million - $28.5 Million
-106,577 Reduced 7.13%
1,388,386 $299 Million
Q4 2023

Feb 13, 2024

SELL
$222.59 - $267.94 $33 Million - $39.7 Million
-148,072 Reduced 9.01%
1,494,963 $387 Million
Q3 2023

Nov 13, 2023

BUY
$253.3 - $285.89 $11.5 Million - $13 Million
45,437 Added 2.84%
1,643,035 $422 Million
Q2 2023

Aug 11, 2023

SELL
$275.25 - $318.06 $20.3 Million - $23.4 Million
-73,691 Reduced 4.41%
1,597,598 $455 Million
Q1 2023

May 15, 2023

SELL
$256.56 - $292.34 $97,492 - $111,089
-380 Reduced 0.02%
1,671,289 $465 Million
Q4 2022

Feb 13, 2023

SELL
$252.44 - $306.72 $3.37 Million - $4.1 Million
-13,352 Reduced 0.79%
1,671,669 $463 Million
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $4.78 Million - $6.59 Million
-24,556 Reduced 1.44%
1,685,021 $450 Million
Q2 2022

Aug 12, 2022

BUY
$187.54 - $223.02 $4.51 Million - $5.36 Million
24,050 Added 1.43%
1,709,577 $349 Million
Q1 2022

May 13, 2022

SELL
$193.77 - $244.14 $1.28 Million - $1.61 Million
-6,595 Reduced 0.39%
1,685,527 $355 Million
Q4 2021

Feb 08, 2022

SELL
$223.92 - $287.77 $15 Million - $19.2 Million
-66,768 Reduced 3.8%
1,692,122 $406 Million
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $87.3 Million - $114 Million
-308,649 Reduced 14.93%
1,758,890 $498 Million
Q2 2021

Aug 13, 2021

SELL
$259.0 - $414.71 $13.7 Million - $22 Million
-52,969 Reduced 2.5%
2,067,539 $716 Million
Q1 2021

May 12, 2021

SELL
$242.95 - $284.63 $19.5 Million - $22.9 Million
-80,450 Reduced 3.66%
2,120,508 $593 Million
Q4 2020

Feb 11, 2021

SELL
$236.26 - $355.63 $43.1 Million - $64.8 Million
-182,232 Reduced 7.65%
2,200,958 $539 Million
Q3 2020

Nov 16, 2020

SELL
$264.77 - $305.71 $14.4 Million - $16.6 Million
-54,446 Reduced 2.23%
2,383,190 $676 Million
Q2 2020

Aug 14, 2020

SELL
$258.66 - $342.55 $8.58 Million - $11.4 Million
-33,166 Reduced 1.34%
2,437,636 $652 Million
Q1 2020

May 14, 2020

SELL
$268.85 - $341.04 $5.5 Million - $6.98 Million
-20,459 Reduced 0.82%
2,470,802 $782 Million
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $66.3 Million - $91.6 Million
-301,394 Reduced 10.79%
2,491,261 $739 Million
Q3 2019

Nov 13, 2019

SELL
$217.44 - $243.88 $19.6 Million - $22 Million
-90,235 Reduced 3.13%
2,792,655 $650 Million
Q2 2019

Aug 13, 2019

SELL
$219.29 - $241.72 $3.57 Million - $3.93 Million
-16,277 Reduced 0.56%
2,882,890 $674 Million
Q1 2019

May 13, 2019

SELL
$216.71 - $338.96 $1.76 Million - $2.76 Million
-8,139 Reduced 0.28%
2,899,167 $685 Million
Q4 2018

Feb 12, 2019

BUY
$278.5 - $352.75 $37.1 Million - $47 Million
133,137 Added 4.8%
2,907,306 $875 Million
Q3 2018

Nov 14, 2018

SELL
$293.51 - $383.83 $34.7 Million - $45.4 Million
-118,390 Reduced 4.09%
2,774,169 $980 Million
Q2 2018

Sep 18, 2018

SELL
$257.52 - $306.91 $3.62 Million - $4.31 Million
-14,055 Reduced 0.48%
2,892,559 $840 Million
Q2 2018

Aug 14, 2018

BUY
$257.52 - $306.91 $8.7 Million - $10.4 Million
33,785 Added 1.18%
2,906,614 $844 Million
Q1 2018

May 09, 2018

SELL
$260.13 - $367.91 $27.7 Million - $39.2 Million
-106,511 Reduced 3.57%
2,872,829 $787 Million
Q4 2017

Feb 14, 2018

SELL
$307.64 - $344.58 $15.2 Million - $17 Million
-49,407 Reduced 1.63%
2,979,340 $949 Million
Q3 2017

Nov 13, 2017

BUY
$281.15 - $329.69 $852 Million - $999 Million
3,028,747
3,028,747 $948 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.